Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, ...

This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...

Après plusieurs années à soigner et accompagner des personnes, nombreux sont les professionnels de santé qui souhaitent ...

Clinical data from the OT‑101 P001 PDAC study suggest targeting TGFB2 merits additional evaluation in younger patients; in a treated subset characterized by low IL‑6, median OS was 12.7 months. † ...

Ryoncil ® is the first and only FDA approved mesenchymal stromal cell (MSC) product in the Unites States and became commercially available for purchase on March 28, 2025, within one quarter of ...

When & Where: Shadow Summit – Monday, July 21 from 10 a.m. to 4:30 p.m. Hidden Valley Resort (next door to the Deerhurst Resort where the Premiers are meeting) 1755 Valley Rd, Huntsville, ON P1H 1A8 ...

Publiée régulièrement en français et en anglais, la Newsletter sera disponible dans la rubrique « Investisseurs » sur le site internet d’OSE Immunotherapeutics. Pour vous inscrire pour recevoir nos ...

The RSU awards and stock options were approved by Lifecore’s compensation committee and were granted as inducement equity awards in accordance with Nasdaq Listing Rule 5635 (c) (4) under the ...

Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced new data for its AI-enabled Heartflow Plaque Analysis, including final primary endpoint data from the ...

Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, Basel and the consortium of ...

This insider transaction follows prior purchases by other members of the board and the new leadership team and reflects growing alignment and confidence in the Company’s operational progress. Hapbee ...

Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call ...